#TTFCovid19: French professor reports success treating Covid-19 patients using malaria drug

According to The Connexion, Didier was tasked and consulted by the French government to research on possible treatments of Covid-19. Source (pic): www.tasnimnews.com

#تتفچوۏيد19: ڤروفيسسور ڤرانچيس لاڤور كجايأن راوت ڤساكيت چوۏيد-19 ڬونا اوبت مالاريا

#TTFCovid19: A French professor is said to have obtained promising results from medical tests on Covid-19 patients by using a new form of treatment.

The professor, Didier Raoult, is an infectious diseases specialist and head of the l’Institut Hospitalo-Universitaire (IHU) Méditerranée Infection in Marseille.

Didier reported successful results with the drug chloroquine where Covid-19 patients saw a rapid and effective speeding up of their healing process and a sharp decrease in the amount of time they remained contagious

Chloroquine is a generic or Chemical term for a drug normally used to prevent and treat malaria and was administered in Didier’s volunteer subjects via the drug brand Plaquenil.


SUBANG JAYA: A French professor is said to have obtained promising results from medical tests on Covid-19 patients by using a new form of treatment.

The professor, Didier Raoult, is an infectious diseases specialist and head of the l’Institut Hospitalo-Universitaire (IHU) Méditerranée Infection in Marseille.




According to French Daily The Connexion, Didier was tasked and consulted by the French government to research on possible treatments of Covid-19.

Didier reported successful results with the drug chloroquine where Covid-19 patients saw a rapid and effective speeding up of their healing process and a sharp decrease in the amount of time they remained contagious

Chloroquine is a generic or Chemical term for a drug normally used to prevent and treat malaria and was administered in Didier’s volunteer subjects via the drug brand Plaquenil.

The volunteer group comprised 24 patients who were among the first to become infected in the south east of France.

According to The Connexion, patients were given 600mcg per day for 10 days and were closely monitored, as the drug can interact with other medication and cause severe side effects.

“We included everyone who was in agreement [to be treated], which was almost everyone. Two towns in the protocol, Nice and Avignon, gave us [infected] patients who had not yet received treatment.

Loading...

“We were able to ascertain that patients who had not received Plaquenil (the drug containing hydroxychloroquine) were still contagious after six days, but of those that had received Plaquenil, after six days, only 25% were still contagious,” Didier said.

Chloroquine phosphate and hydroxychloroquine have previously been used to treat coronavirus patients in China, in ongoing Covid-19 clinical trials.

Kaletra, a US-based antiviral drug normally used to treat HIV, is another medicine that is being tested in the fight against Covid-19.

THE THIRD FORCE



Your donation is much appreciated and will go a long way towards helping us serve you better. Click the donate button below to make a contribution (you don't need a Paypal account to donate through Paypal, simply follow the instructions once you click the button).


SUBSCRIBE TO US ON YOUTUBE:



YOUTUBE: THE THIRD FORCE

TELEGRAM: Raggie Jessy Rithaudeen

TWITTER: Raggie Jessy Rithaudeen

WEBSITE: raggiejessyrithaudeen.com

Loading...

COMMENTS

Comments

Comments



Loading...